The University Health Network, where "above all else the needs of patients come first", encompasses Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute of Education. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of ground breaking firsts and a purpose of "Transforming lives and communities through excellence in care, discovery and learning", the University Health Network (UHN), Canada's largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.
Union: Non-Union
Site: Princess Margaret Cancer Centre
Department: Cancer Genomics Program (CGP), Tumor Immunotherapy Program (TIP), and Phase I Drug Development Program (DDP1)
Reports to: Senior Program Manager, Cancer Genomics Program
Work Model: Hybrid (on-site 1 day per week, remote 4 days per week)
Grade: N0:08
Hours: 37.5 hours per week
Salary: $76,655 - $95,823 annually (To be commensurate with experience and consistent with UHN compensation policy)
Shifts: Monday - Friday
Status: Permanent Full-Time
Closing Date: November 22, 2024
The Cancer Genomics Program (CGP), Tumor Immunotherapy Program (TIP), and Phase I Drug Development Program (DDP1) are jointly seeking an Interprogram Research Quality Associate to coordinate and execute quality assurance (QA) efforts across the three clinical research programs. The ideal candidate is an experienced clinical research professional with clinical data collection expertise and a deep familiarity with the regulations and guidelines governing clinical research in human subjects. The Research Quality Associate will work closely with the CGP, TIP, and DDP1 Clinical Research Managers to plan and implement data monitoring activities for a breadth of investigator-initiated studies that span genomics, immunotherapy, cell therapy, and first-in-human trials across all malignant disease types.
Duties:
Why join UHN?
In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.
Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN's attendance management program, to be eligible for consideration.
All applications must be submitted before the posting close date.
UHN uses email to communicate with selected candidates. Please ensure you check your email regularly.
Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.
UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.
We thank all applicants for their interest, however, only those selected for further consideration will be contacted.